WAT
$468.55+2.76%
as of close, Oct 27, 2026
☾ AH $468.55 +2.76%
WAT — Waters Corporation price, chart and key statistics
Technical analysis2
Overlay lines0
Addendum charts0
VolumeEEEEEEEEEEEEEEEEEEEEE
150.0200.0250.0300.0350.0400.0450.005.0M10.0M$468.55—20162019202120242026
2026-10-27
Price$468.55
MA20$398.09
MA50$365.41
Vol3.9M
Key stats#
Price data
- Price
- $468.55
- YTD price return
- +23.36%
- YTD total return
- +23.36%
- Next earnings
- Nov 3, 2026 · Before open
- Market cap
- 46B
- Enterprise value
- 50.7B
- Shares outstanding
- 98.2M
- 52W low
- $282.77
- 52W high
- $470.85
- From 52W high
- -0.49%
- From 52W low
- +65.70%
- 52W range
- 99%
- Beta
- 1.19
Volume
- Rel volume
- 0.92×
- 30D volume
- 862.8K
- 30D $ vol
- 377.3M
Insider trading
- Insider net 1W
- none
- Insider net 1M
- none
- Insider net 3M
- −$1.4M
- Insider net 1Y
- −$992K
Form 4 transactions by trade date, as filed; latest on file 2026-08-06.
Fundamentals
- Sales (ttm)
- 4.6B
- Sales/share
- $47.27
- EPS (ttm)
- $4.01
- FCF (ttm)
- 398.8M
- FCF/share
- $4.06
- Book value/share
- $154.66
- Net margin
- 3.58%
- ROE
- 1.09%
- ROA
- 0.67%
- Debt / equity
- 0.32×
- Current ratio
- 1.86
Growth (CAGR, ttm) · 10Y
- Sales
- +51.48%+15.73%+11.70%+8.26%
- Net income
- -74.32%-37.23%-24.11%-10.24%
- FCF
- n/a-4.03%n/an/a
- Shares
- +63.78%+18.40%+9.87%+2.00%
Per-share growth (CAGR, ttm) · 10Y
- EPS
- -63.27%-29.21%-17.63%-3.88%
- Sales/share
- -7.51%-2.26%+1.67%+6.14%
- FCF/share
- n/a-21.58%n/an/a
- Book value/share
- +316.73%+127.44%+103.99%+19.21%
- Price
- +33.23%+24.16%+5.34%+13.05%
- Total return
- +33.23%+24.16%+5.34%+13.05%
Fundamentals end at the last reported quarter; price and total return end at the latest close.
Valuation
- P/E (ttm)
- 116.8×
- P/OI (ttm)
- 139.7×
- Fwd P/E
- 27.4×
- P/S (ttm)
- 9.9×
- P/B (mrq)
- 3.0×
- P/FCF (ttm)
- 115.4×
- EV/EBITDA (fy)
- 53.8×
- EV/Sales (ttm)
- 10.9×
- FCF yield (ttm)
- 0.87%
- Buyback yield (realized, 1y)
- -63.78%
- Shareholder yield (realized, 1y)
- -63.78%
- Buyback yield (cash, ttm)
- 0.03%
- Shareholder yield (cash, ttm)
- 0.03%
Vs own 10Y history
- P/E
- 92nd
- P/OI
- 100th
- P/S
- 98th
- P/B
- 6th
Bar = where today’s multiple sits in WAT’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).
Performance · price return · as of 2026-10-27#
1D
+2.76%
5D
+5.81%
1M
+8.08%
3M
+26.23%
YTD
+23.36%
1Y
+33.21%
5Y
+29.73%
Recent filings#
- Aug 6Insider sale · KUEBLER CHRISTOPHER A (Director) sold 3,626 shares for $1.4M at $397.94
- Aug 4Earnings · Earnings release — EPS $3.05 vs $3.01 est. (+1.3%); revenue $1.65B (+113% y/y) 5.7%
Financial statements
Open full WAT financials →Loading financial statements…
Related Healthcare#
| Ticker | Name | 1M | 1D |
|---|---|---|---|
| LLY | Eli Lilly and Company | +8.32% | +0.22% |
| JNJ | Johnson & Johnson | -0.92% | +0.91% |
| ABBV | AbbVie Inc. | +8.34% | -0.12% |
| UNH | UnitedHealth Group Incorporated Common Stock (DE) | +8.98% | -0.08% |
| MRK | Merck & Co. Inc. | -4.68% | +0.86% |
| NVS | Novartis AG | +7.84% | +1.98% |
| TMO | Thermo Fisher Scientific Inc. | +2.67% | +1.19% |
| AMGN | Amgen Inc. | +8.04% | +0.75% |
